These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1881399)

  • 1. Production of interleukin-1 and tumor necrosis factor by cisplatin-treated murine peritoneal macrophages.
    Singh RK; Sodhi A; Singh SM
    Nat Immun Cell Growth Regul; 1991; 10(2):105-16. PubMed ID: 1881399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the release of interleukin-1 (IL-1), tumor necrosis factor (TNF) and lysozyme from human non-adherent mononuclear cells (nMNC) in vitro after treatment with cisplatin and other biological response modifiers.
    Sodhi A; Pai K
    Neoplasma; 1992; 39(4):211-7. PubMed ID: 1436230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Phytolacca acinosa polysaccharides I on cytotoxicity of macrophages and its production of tumor necrosis factor and interleukin 1].
    Zhang JP; Qian DH; Zheng QY
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):375-7. PubMed ID: 2104493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. Involvement of cell-associated tumor necrosis factor and reactive nitrogen.
    Ayala A; Perrin MM; Wang P; Ertel W; Chaudry IH
    J Immunol; 1991 Dec; 147(12):4147-54. PubMed ID: 1753090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effect of Dalton's lymphoma cells on the production of reactive nitrogen intermediates, interleukin-1 and tumor necrosis factor by murine peritoneal macrophages.
    Kumar A; Singh SM; Parajuli P
    Neoplasma; 1994; 41(6):363-9. PubMed ID: 7870222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of allogenic Dalton's lymphoma cells on the activation of murine peritoneal macrophages to tumoricidal state by cisplatin and lipopolysaccharide (LPS).
    Singh SM; Singh RK; Sodhi A
    Neoplasma; 1992; 39(3):151-5. PubMed ID: 1528319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of tumor cytolytic/cytostatic factor(s) by in vitro cisplatin treated macrophages: enhanced tumoricidal activity by increase in osmotic fragility of target cells.
    Singh SM; Sodhi A; Pai K; Geetha B
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):67-73. PubMed ID: 1804054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential production of tumor necrosis factor, macrophage colony stimulating factor, and interleukin 1 by human alveolar macrophages.
    Becker S; Devlin RB; Haskill JS
    J Leukoc Biol; 1989 Apr; 45(4):353-61. PubMed ID: 2649630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro.
    Bromander A; Holmgren J; Lycke N
    J Immunol; 1991 May; 146(9):2908-14. PubMed ID: 1901890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K; Mihich E; Ehrke MJ
    Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced immune system activation after treatment with novel antineoplastic platinum agents.
    Muenchen HJ; Aggarwal SK
    Anticancer Res; 1998; 18(4A):2631-6. PubMed ID: 9703920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of C3H/HeJ macrophage tumoricidal activity and cytokine release by R-chemotype lipopolysaccharide preparations. Differential effects of IFN-gamma.
    Flebbe LM; Chapes SK; Morrison DC
    J Immunol; 1990 Sep; 145(5):1505-11. PubMed ID: 2117032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiating effect of granulocyte-macrophage colony-stimulating factor on interleukin-1-induced thymocyte proliferation: evidence for an interleukin-2 and tumor necrosis factor-independent pathway.
    Herbelin A; Machavoine F; Dy M
    Lymphokine Res; 1990; 9(2):155-65. PubMed ID: 2187117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of macrophages with Hochu-ekkito].
    Kataoka T; Akagawa KS; Tokunaga T; Nagao S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1490-3. PubMed ID: 2499265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine eosinophils and IL-1: alpha IL-1 mRNA detection by in situ hybridization. Production and release of IL-1 from peritoneal eosinophils.
    Del Pozo V; De Andres B; Martin E; Maruri N; Zubeldia JM; Palomino P; Lahoz C
    J Immunol; 1990 Apr; 144(8):3117-22. PubMed ID: 2109011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C; Temime N; Charron DJ; Parant MA
    J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes.
    McBride WH; Economou JS; Nayersina R; Comora S; Essner R
    Cancer Res; 1990 May; 50(10):2949-52. PubMed ID: 2334896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
    Heidenreich S; Gong JH; Schmidt A; Nain M; Gemsa D
    J Immunol; 1989 Aug; 143(4):1198-205. PubMed ID: 2473121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo activation of murine peritoneal macrophages by intraperitoneal administration of cisplatin.
    Sodhi A; Gupta P; Singh SM
    Arch Immunol Ther Exp (Warsz); 1988; 36(3):303-14. PubMed ID: 3266918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.